Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

±Þ¼º ºñƯÀ̼º Àå°£¸· ¸²ÇÁÀý¿°ÀÇ ÀÓ»ó ¼Ò°ß°ú ±Þ¼º Ãæ¼öµ¹±â¿°°úÀÇ °¨º° ÀÎÀÚ Clinical Features of Acute Nonspecific Mesenteric Lymphadenitis and Factors for Differential Diagnosis with Acute Appendicitis.

´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸÁö 2004³â 7±Ç 1È£ p.31 ~ 39
½Å°æÈ­, °¨½Å, ÀÌ¿µÈ¯, ȲÁøº¹, ±è°©Ã¶, ÀÌÁ¤±Ç,
¼Ò¼Ó »ó¼¼Á¤º¸
½Å°æÈ­ ( Shin Kyung-Hwa ) 
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç

°¨½Å ( Kam Sin ) 
°æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ ¿¹¹æÀÇÇб³½Ç
ÀÌ¿µÈ¯ ( Lee Young-Hwan ) 
´ë±¸°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¹æ»ç¼±°úÇб³½Ç
ȲÁøº¹ ( Hwang Jin-Bok ) 
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
±è°©Ã¶ ( Kim Gab-Cheol ) 
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ Ä¡·á¹æ»ç¼±°úÇб³½Ç
ÀÌÁ¤±Ç ( Lee Jung-Kwon ) 
ÇÑ¿µÇѸ¶À½¿¬ÇռҾưúÀÇ¿ø

Abstract

¸ñ Àû: ±Þ¼º ºñƯÀ̼º Àå°£¸· ¸²ÇÁÀý¿°(acute nonspecific mesenteric lymphadenitis, ANML)Àº Ÿ ÁúȯÀÌ ÀûÀýÈ÷ ¹èÁ¦µÇ¾úÀ» ¶§ ÀÓ»óÀû ÃßÁ¤À¸·Î Áø´ÜÇÏ´Â °æ¿ì°¡ ¸¹¾Æ ±× ½Çü¿¡ ´ëÇÏ¿©´Â Àß ¾Ë·ÁÁ® ÀÖÁö ¾Ê´Ù. ƯÈ÷ ±Þ¼º Ãæ¼ö µ¹±â¿°(acute appendicitis, APPE)°úÀÇ °¨º°¿¡ È¥¶õÀ» ÁÖ¾î º¹¸·¿° µîÀ¸·Î ÀÌÇàµÇ´Â °æ¿ì°¡ µå¹°Áö ¾Ê´Ù. ANMLÀÇ ÀÓ»ó ¼Ò°ßÀ» º¸°íÇÏ°í, ƯÈ÷ APPE¿ÍÀÇ °¨º°½Ã µµ¿òÀ» ÁÙ ¼ö ÀÖ´Â Á¢±Ù ¹æ½ÄÀ» ¿¬±¸ÇÏ°íÀÚ ÇÑ´Ù.

¹æ ¹ý: 2000³â 11¿ùºÎÅÍ 2001³â 5¿ù±îÁö ´ë±¸½Ã ÇÑ¿µÇѸ¶À½¿¬ÇռҾưúÀÇ¿øÀ¸·Î ±Þ¼º º¹ÅëÀ» ÁÖ¼Ò·Î ³»¿øÇÏ¿© ANML·Î Áø´ÜµÈ 26¸í(³²³àºñ 13£º13)À», APPE ȯÀÚ´Â °°Àº ±â°£ ´ë±¸°¡Å縯´ëÇк´¿øÀ» ¹æ¹®ÇÏ¿© ¼ö¼ú¹ÞÀº 21¸í(³²³àºñ 12£º9)À» ´ë»óÀ¸·Î ÇÏ¿´´Ù. ANML ȯÀÚµéÀº º¹ºÎ ÃÊÀ½ÆÄ °Ë»ç»ó 10 mm ÀÌ»ó, 5°³ ÀÌ»óÀÇ Àå°£¸· ¸²ÇÁÀýÀÌ °üÂûµÇ¸é¼­ ȸÀå, ´ëÀåÀÇ À庮 ºñÈÄ ¼Ò°ßÀÌ 5 mm¸¦ ³ÑÁö ¾Ê°í ¿°Áõ¼º Ãæ¼öµ¹±â°¡ °üÂûµÇÁö ¾ÊÀ¸¸ç, ¸»ÃÊ Ç÷¾× °Ë»ç, ¼Òº¯ °Ë»ç, ´ëº¯ °Ë»ç»ó Ÿ ÁúȯÀ» ÀǽÉÇÒ ¼Ò°ßÀÌ ¾ø´Â µîÀ» Áø´Ü±âÁØÀ¸·Î ¼³Á¤ÇÏ¿´´Ù.

°á °ú: 1) ANML±ºÀÇ Áø´Ü ´ç½Ã ¿¬·ÉÀº 1¡­11¼¼, 5.2?2.3¼¼¿´´Ù. 2) ANML±ºÀÇ º¹Åë ¾ç»óÀº 21·Ê(80%)¿¡¼­ ¾ß°£ º¹ÅëÀÌ ÀÖ¾ú°í, À§Ä¡´Â ¹è²Å ÁÖÀ§ºÎ 20·Ê(76%), ¿ìÇϺ¹ºÎ 3·Ê(11%), ÇϺ¹ºÎ 3·Ê(11%)¿´´Ù. 2·Ê(7%)¿¡¼­ º¹ºÎ °­Á÷ÀÌ ÀÖ¾ú°í, ¹Ý¹ß ¾ÐÅëÀº Àü·Ê¿¡¼­ ¾ø¾ú´Ù. APPE±º¿¡¼­´Â Àü·Ê¿¡¼­ ¾ß°£ º¹ÅëÀÌ ÀÖ¾ú°í, 17·Ê(80%)¿¡¼­ º¹ºÎ °­Á÷ÀÌ, 16·Ê(76%)¿¡¼­ ¹Ý¹ß ¾ÐÅëÀÌ °üÂûµÇ¾î ANML±º°ú °¢°¢ À¯ÀÇÇÑ Â÷À̸¦ º¸¿´´Ù(p£¼0.05). 3) ANML±º¿¡¼­ º¹ÅëÀÇ È¸º¹±îÁö °É¸° ½Ã°£Àº 2¡­4ÀÏ, 2.5?0.5ÀÏÀ̾ú´Ù. 4) ANML±º 10·Ê(38%)¿¡¼­ ±¸Å並 º¸¿´°í 1¡­3ȸ/ÀÏ, 1.5?0.7ȸ/ÀÏÀ̾ú´Ù. ¼³»ç´Â 17·Ê(65%)¿¡¼­ ÀÖ¾ú°í 1¡­4ȸ/ÀÏ, 1.6?0.8ȸ¿´´Ù. APPE±º 19·Ê(90%)¿¡¼­ ±¸Åä°¡ ÀÖ¾úÀ¸¸ç 1¡­10ȸ/ÀÏ, 4.5?2.9ȸ·Î ANML±º°ú À¯ÀÇÇÑ Â÷À̸¦ º¸¿´´Ù(p£¼0.05). APPE±ºÀÇ ¼³»ç´Â 6·Ê(28%)¿¡¼­ ÀÖ¾úÀ¸¸ç 1¡­5ȸ/ÀÏ, 2.1?1.6ȸÀ̾ú´Ù. 5) ANML±º¿¡¼­ ¿­Àº 19·Ê(73%)¿¡¼­ ÀÖ¾ú°í, ¸»ÃÊÇ÷¾× ¹éÇ÷±¸ ¼ö´Â 5,900¡­12,300/mm3À̾úÀ¸¸ç Æò±Õ 8,403?1,737/mm3À̾ú´Ù. APPE±º¿¡¼­´Â ¿­Àº 16·Ê(76%)¿¡¼­ °üÂûµÇ¾úÀ¸¸ç ¹éÇ÷±¸ ¼ö´Â 5,400¡­20,800/mm3À¸·Î Æò±Õ 15,471?3,749/mm3À̾úÀ¸¸ç ANML±º°ú´Â À¯ÀÇÇÑ Â÷À̸¦ º¸¿´´Ù(p£¼0.05). 6) ÆǺ°ºÐ¼®À» ÀÌ¿ëÇÏ¿© ÇÏ·ç ±¸ÅäÀÇ °­µµ¿Í ¹éÇ÷±¸ ¼ö¸¦ µ¶¸³º¯¼ö·Î ÇÏ¿´À» ¶§ ANML°ú APPE´Â 95.7% ¼öÁØÀ¸·Î ºÐ·ùµÇ¾ú´Ù.

°á ·Ð: ANML°ú APPEÀÇ °¨º° ½Ã º¹ºÎ°­Á÷, ¹Ýµ¿¾ÐÅë µî ±Þ¼ºº¹ÁõÀÇ ¼Ò°ßÀÌ ÀÇ½ÉµÉ ¶§ »Ó¸¸ ¾Æ´Ï¶ó, º¹ÅëÀÌ 3ÀÏÀ» ÃÊ°úÇÏ¿© Áö¼ÓµÇ°Å³ª, ÇÏ·ç ±¸Åä°¡ 3ȸ¸¦ ÃÊ°úÇÏ´Â °æ¿ì, ¸»ÃÊÇ÷¾×°Ë»ç»ó ¹éÇ÷±¸ ¼ö°¡ 13,500/mm3 ÀÌ»óÀ» º¸ÀÏ ¶§¿¡µµ ¹Ýµå½Ã º¹ºÎÃÊÀ½ÆÄ °Ë»ç¸¦ ÀÌ¿ëÇÏ¿© APPE¸¦ È®ÀÎÇÏ¿©¾ß ÇÑ´Ù.

Purpose:Although acute nonspecific mesenteric lymphadenitis (ANML) is probably common cause of abdominal pain in children, which can be severe enough to be an abdominal emergency, the clinical features of mesenteric lymphadenitis are not clear. Also, a differential diagnosis with acute appendicitis (APPE) is indispensable to avoid serious complications. The clinical features of ANML were determined, and the risk factors for differential diagnosis with APPE were analyzed.

Methods:Between November 2000 and May 2001, data from 26 patients (aged 1 to 11 years) with ANML and 21 patients (aged 2 to 13 years) with APPE were reviewed. ANML was defined as a cluster of five or more lymph nodes measuring 10 mm or greater in their longitudinal diameter in the right lower quadrant (RLQ) without an identifiable specific inflammatory process on the ultrasonographic examination. There were risk factors on patient¡¯s history, physical examination, and laboratory examination; the location of abdominal pain, abdominal rigidity, rebound tenderness, fever, nocturnal pain, the vomiting intensity, the diarrhea intensity, the symptom duration, and the peripheral blood leukocytes count.

Results:Of the 26 ANML patients and 21 APPE patients, abdominal pain was noted on periumbilical (76.9% vs 14.2%), on RLQ (11.5% vs 71.4%), with abdomen rigidity (7.6% vs 80.9%), with rebound tenderness (0.0% vs 76.1%)(p<0.05), in the lower abdomen (11.5% vs 14.2%), and at night (80.8% vs 100.0%) (p>0.05). The clinical symptoms were vomiting (38.4% vs 90.4%), the vomiting intensity (1.5+/-0.7 [1~3] /day vs 4.5+/-2.9 [1~10] /day), diarrhea (65.3% vs 28.5%) (p<0.05), and fever (61.5% vs 76.2%)(p>0.05). The period to the subsidence of abdominal pain in the ANMA patients was 2.5+/-0.5 (2~3) days. The laboratory data showed a significant difference in the peripheral blood leukocytes count (8,403+/-1,737 [5,900~12,300] /mm3 vs 15,471+/-3,749 [5,400~20,800] /mm3)(p<0.05). Discriminant analysis between ANML and APPE showed that the independent discriminant factors were a vomiting intensity and the peripheral blood leukocytes count and the discriminant power was 95.7%.

Conclusion:The clinical characteristics of ANML were abrupt onset of periumbilical pain without rigidity or rebound tenderness, a mild vomiting intensity, normal peripheral leukocytes count, and relatively short clinical course. If the abdominal pain persist for more than 3 days, and/or the vomiting intensity is more than 3 times/day, and/or the peripheral leukocytes count is over 13,500/mm3, abdominal ultrasonography is recommended to rule out APPE.

Å°¿öµå

Mesenterinc;Lymphadenitis;Acute appendicitis

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS